Last 12 months
Inside the activity.
0 purchase rows · 17 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 4 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 18, 2022 Filed Jan 21, 2022 00:24 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
Exercise / conversionCommon Stock | 6,338 | $43.54 | $275,956.52 |
DisclosureSEC source: 0001209191-22-004202 · doc4.xml · nonDerivative · entry 3 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,581 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| January 18, 2022 Filed Jan 21, 2022 00:24 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
Exercise / conversionCommon Stock | 2,600 | $38.35 | $99,710.00 |
DisclosureSEC source: 0001209191-22-004202 · doc4.xml · nonDerivative · entry 2 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,243 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| January 18, 2022 Filed Jan 21, 2022 00:24 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
Exercise / conversionCommon Stock | 1,375 | $44.20 | $60,775.00 |
DisclosureSEC source: 0001209191-22-004202 · doc4.xml · nonDerivative · entry 1 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| January 18, 2022 Filed Jan 21, 2022 00:21 UTC |
MOLLOY ANTHONYChief Lgl & Compliance Officer
|
SaleCommon Stock | 224 | $63.55 | $14,235.20 |
DisclosureSEC source: 0001209191-22-004198 · doc4.xml · nonDerivative · entry 1 MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,550 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| January 18, 2022 Filed Jan 21, 2022 00:22 UTC |
RIKER LAURENSenior Vice President, Finance
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $10.81 | $0.00 |
DisclosureSEC source: 0001209191-22-004200 · doc4.xml · derivative · entry 3 Riker Lauren Bullaro · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,300 Underlying: Common Stock · 2,500 shares Expires 2022-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months. Read SEC document |
| January 18, 2022 Filed Jan 21, 2022 00:22 UTC |
RIKER LAURENSenior Vice President, Finance
|
SaleCommon Stock | 2,500 | $64.97 | $162,430.00 |
DisclosureSEC source: 0001209191-22-004200 · doc4.xml · nonDerivative · entry 2 Riker Lauren Bullaro · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,152 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| January 18, 2022 Filed Jan 21, 2022 00:22 UTC |
RIKER LAURENSenior Vice President, Finance
|
Exercise / conversionCommon Stock | 2,500 | $10.81 | $27,025.00 |
DisclosureSEC source: 0001209191-22-004200 · doc4.xml · nonDerivative · entry 1 Riker Lauren Bullaro · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 16:11 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $10.81 | $0.00 |
DisclosureSEC source: 0001209191-22-003176 · doc4.xml · derivative · entry 5 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,670 Underlying: Common Stock · 15,000 shares Expires 2022-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 16:11 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionCommon Stock | 15,000 | $10.81 | $162,150.00 |
DisclosureSEC source: 0001209191-22-003176 · doc4.xml · nonDerivative · entry 1 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 289 shares of common stock acquired under the issuer's employee stock purchase plan in December 2021. Read SEC document |
| January 04, 2022 Filed Jan 10, 2022 22:32 UTC |
RIKER LAURENSenior Vice President, Finance
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $61.60 | $0.00 |
DisclosureSEC source: 0001209191-22-002726 · doc4.xml · derivative · entry 2 Riker Lauren Bullaro · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2032-01-04 F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on December 7, 2022, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| January 04, 2022 Filed Jan 10, 2022 22:32 UTC |
RIKER LAURENSenior Vice President, Finance
|
GrantCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-002726 · doc4.xml · nonDerivative · entry 1 Riker Lauren Bullaro · CIK 0001545439 · Senior Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,152 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on January 2, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| January 04, 2022 Filed Jan 10, 2022 22:28 UTC |
MOLLOY ANTHONYChief Lgl & Compliance Officer
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $61.60 | $0.00 |
DisclosureSEC source: 0001209191-22-002725 · doc4.xml · derivative · entry 2 MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2032-01-04 F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on December 7, 2022, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| January 04, 2022 Filed Jan 10, 2022 22:28 UTC |
MOLLOY ANTHONYChief Lgl & Compliance Officer
|
GrantCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-002725 · doc4.xml · nonDerivative · entry 1 MOLLOY ANTHONY · CIK 0001900012 · Chief Lgl & Compliance Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,774 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on January 2, 2023, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. F2 · balance_after: Includes 224 shares of common stock acquired under the issuer's employee stock purchase plan in December 2021. Read SEC document |
| December 17, 2021 Filed Dec 20, 2021 16:13 UTC |
Froimson MarkDirector
|
GiftCommon Stock | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070553 · doc4.xml · nonDerivative · entry 1 Froimson Mark · CIK 0001709050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,908 Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 21:25 UTC |
LARANJEIRA CHARLES ANTHONYChief Technical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $44.10 | $0.00 |
DisclosureSEC source: 0001209191-21-066795 · doc4.xml · derivative · entry 2 LARANJEIRA CHARLES ANTHONY · CIK 0001524338 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2027-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on May 1, 2018, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remained in continuous service with the issuer as of each vesting date. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 21:25 UTC |
LARANJEIRA CHARLES ANTHONYChief Technical Officer
|
Exercise / conversionCommon Stock | 7,500 | $44.10 | $330,750.00 |
DisclosureSEC source: 0001209191-21-066795 · doc4.xml · nonDerivative · entry 1 LARANJEIRA CHARLES ANTHONY · CIK 0001524338 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,602 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 421 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021. Read SEC document |
| November 16, 2021 Filed Nov 18, 2021 16:22 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $10.81 | $0.00 |
DisclosureSEC source: 0001209191-21-065463 · doc4.xml · derivative · entry 5 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,670 Underlying: Common Stock · 15,000 shares Expires 2022-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months. Read SEC document |
| November 16, 2021 Filed Nov 18, 2021 16:22 UTC |
STACK DAVID MDirector · CEO and Chairman
|
Exercise / conversionCommon Stock | 15,000 | $10.81 | $162,150.00 |
DisclosureSEC source: 0001209191-21-065463 · doc4.xml · nonDerivative · entry 1 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,085 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 129 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021. Read SEC document |
| November 04, 2021 Filed Nov 8, 2021 21:22 UTC |
WINSTON ROYChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $48.15 | $0.00 |
DisclosureSEC source: 0001209191-21-063386 · doc4.xml · derivative · entry 2 WINSTON ROY · CIK 0001751757 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 10,000 shares Expires 2027-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option vested and became exercisable as to 25% of the option shares on the first anniversary of the grant date, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years. Read SEC document |
| November 04, 2021 Filed Nov 8, 2021 21:22 UTC |
WINSTON ROYChief Medical Officer
|
Exercise / conversionCommon Stock | 10,000 | $48.15 | $481,500.00 |
DisclosureSEC source: 0001209191-21-063386 · doc4.xml · nonDerivative · entry 1 WINSTON ROY · CIK 0001751757 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 20:29 UTC |
SLONIN JONATHANChief Clinical Officer
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $60.79 | $0.00 |
DisclosureSEC source: 0001209191-21-049940 · doc4.xml · derivative · entry 2 SLONIN JONATHAN · CIK 0001875723 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-07-20 F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on July 20, 2022, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 20:29 UTC |
SLONIN JONATHANChief Clinical Officer
|
GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-049940 · doc4.xml · nonDerivative · entry 1 SLONIN JONATHAN · CIK 0001875723 · Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,350 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on August 1, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 20:33 UTC |
WINSTON ROYChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $60.79 | $0.00 |
DisclosureSEC source: 0001209191-21-049945 · doc4.xml · derivative · entry 2 WINSTON ROY · CIK 0001751757 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-07-20 F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on June 20, 2022, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 20:33 UTC |
WINSTON ROYChief Medical Officer
|
GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-049945 · doc4.xml · nonDerivative · entry 1 WINSTON ROY · CIK 0001751757 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,456 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on August 1, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. F2 · balance_after: Includes 421 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021. Read SEC document |
| July 29, 2021 Filed Jul 30, 2021 20:21 UTC |
RIKER LAURENVice President, Finance
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 90 | $0.00 Strike: $10.81 | $0.00 |
DisclosureSEC source: 0001209191-21-048784 · doc4.xml · derivative · entry 6 Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,800 Underlying: Common Stock · 90 shares Expires 2022-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months. Read SEC document |
| July 29, 2021 Filed Jul 30, 2021 20:21 UTC |
RIKER LAURENVice President, Finance
|
SaleCommon Stock | 90 | $60.81 | $5,472.90 |
DisclosureSEC source: 0001209191-21-048784 · doc4.xml · nonDerivative · entry 4 Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,152 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| July 29, 2021 Filed Jul 30, 2021 20:21 UTC |
RIKER LAURENVice President, Finance
|
Exercise / conversionCommon Stock | 90 | $10.81 | $972.90 |
DisclosureSEC source: 0001209191-21-048784 · doc4.xml · nonDerivative · entry 3 Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Read SEC document |
| July 28, 2021 Filed Jul 30, 2021 20:21 UTC |
RIKER LAURENVice President, Finance
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,410 | $0.00 Strike: $10.81 | $0.00 |
DisclosureSEC source: 0001209191-21-048784 · doc4.xml · derivative · entry 5 Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,890 Underlying: Common Stock · 2,410 shares Expires 2022-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months. Read SEC document |
| July 28, 2021 Filed Jul 30, 2021 20:21 UTC |
RIKER LAURENVice President, Finance
|
SaleCommon Stock | 2,410 | $60.85 | $146,648.50 |
DisclosureSEC source: 0001209191-21-048784 · doc4.xml · nonDerivative · entry 2 Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,152 F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.81 to $60.858, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 28, 2021 Filed Jul 30, 2021 20:21 UTC |
RIKER LAURENVice President, Finance
|
Exercise / conversionCommon Stock | 2,410 | $10.81 | $26,052.10 |
DisclosureSEC source: 0001209191-21-048784 · doc4.xml · nonDerivative · entry 1 Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,562 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · balance_after: Includes 421 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021. Read SEC document |
| July 02, 2021 Filed Jul 6, 2021 22:14 UTC |
REINHARDT MAXPresident, Rest of World
|
SaleCommon Stock | 421 | $59.76 | $25,158.96 |
DisclosureSEC source: 0001209191-21-045622 · doc4.xml · nonDerivative · entry 1 REINHARDT MAX · CIK 0001780058 · President, Rest of World 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F2 · balance_after: Includes 421 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021. Read SEC document |
| June 11, 2021 Filed Jun 12, 2021 00:39 UTC |
RIKER LAURENVice President, Finance
|
SaleCommon Stock | 2,003 | $59.85 | $119,879.55 |
DisclosureSEC source: 0001209191-21-040092 · doc4.xml · nonDerivative · entry 2 Riker Lauren Bullaro · CIK 0001545439 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,731 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.820 to $59.845, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth this footnote. Read SEC document |
| June 10, 2021 Filed Jun 12, 2021 00:38 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
SaleCommon Stock | 847 | $60.57 | $51,302.79 |
DisclosureSEC source: 0001209191-21-040090 · doc4.xml · nonDerivative · entry 3 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,268 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.20 to $60.92, inclusive. Read SEC document |
| June 10, 2021 Filed Jun 12, 2021 00:38 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
SaleCommon Stock | 4,842 | $59.43 | $287,760.06 |
DisclosureSEC source: 0001209191-21-040090 · doc4.xml · nonDerivative · entry 2 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,115 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.03 to $59.99, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 and 4. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:35 UTC |
Manning Donald C.Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $60.96 | $0.00 |
DisclosureSEC source: 0001209191-21-040088 · doc4.xml · derivative · entry 2 Manning Donald C. · CIK 0001775268 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-06-09 F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:35 UTC |
Manning Donald C.Chief Medical Officer
|
GrantCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040088 · doc4.xml · nonDerivative · entry 1 Manning Donald C. · CIK 0001775268 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,520 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:32 UTC |
Froimson MarkDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,626 | $0.00 Strike: $60.96 | $0.00 |
DisclosureSEC source: 0001209191-21-040082 · doc4.xml · derivative · entry 2 Froimson Mark · CIK 0001709050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,626 Underlying: Common Stock · 7,626 shares Expires 2031-06-09 Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:32 UTC |
Froimson MarkDirector
|
GrantCommon Stock | 1,066 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040082 · doc4.xml · nonDerivative · entry 1 Froimson Mark · CIK 0001709050 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,308 F1 · shares: Represents restricted stock units that vest on June 3, 2022, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:40 UTC |
Reinhart Charles A. IIIChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $60.96 | $0.00 |
DisclosureSEC source: 0001209191-21-040093 · doc4.xml · derivative · entry 2 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-06-09 F2 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:40 UTC |
Reinhart Charles A. IIIChief Financial Officer
|
GrantCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040093 · doc4.xml · nonDerivative · entry 1 Reinhart Charles A. III · CIK 0001470871 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,799 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:32 UTC |
Greenstreet YvonneDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,626 | $0.00 Strike: $60.96 | $0.00 |
DisclosureSEC source: 0001209191-21-040083 · doc4.xml · derivative · entry 2 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,626 Underlying: Common Stock · 7,626 shares Expires 2031-06-09 Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:32 UTC |
Greenstreet YvonneDirector
|
GrantCommon Stock | 1,066 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040083 · doc4.xml · nonDerivative · entry 1 Greenstreet Yvonne · CIK 0001446125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,087 F1 · shares: Represents restricted stock units that vest on June 3, 2022, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 09, 2021 Filed Jun 12, 2021 00:38 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $60.96 | $0.00 |
DisclosureSEC source: 0001209191-21-040090 · doc4.xml · derivative · entry 4 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Common Stock · 17,500 shares Expires 2031-06-09 F5 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 09, 2021 Filed Jun 12, 2021 00:38 UTC |
WILLIAMS KRISTENChief Administrative Officer
|
GrantCommon Stock | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040090 · doc4.xml · nonDerivative · entry 1 Williams Kristen Marie · CIK 0001296965 · Chief Administrative Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,957 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:35 UTC |
LONGENECKER JOHN P PHDDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,626 | $0.00 Strike: $60.96 | $0.00 |
DisclosureSEC source: 0001209191-21-040087 · doc4.xml · derivative · entry 2 LONGENECKER JOHN P PHD · CIK 0001288231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,626 Underlying: Common Stock · 7,626 shares Expires 2031-06-09 Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:35 UTC |
LONGENECKER JOHN P PHDDirector
|
GrantCommon Stock | 1,066 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040087 · doc4.xml · nonDerivative · entry 1 LONGENECKER JOHN P PHD · CIK 0001288231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,823 F1 · shares: Represents restricted stock units that vest on June 3, 2022, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:38 UTC |
STACK DAVID MDirector · CEO and Chairman
|
GrantStock Option (Right to Buy) · Derivative | 133,400 | $0.00 Strike: $60.96 | $0.00 |
DisclosureSEC source: 0001209191-21-040091 · doc4.xml · derivative · entry 5 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,400 Underlying: Common Stock · 133,400 shares Expires 2031-06-09 F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the option shares on the first anniversary of the grant date, and vests as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Read SEC document |
| June 09, 2021 Filed Jun 11, 2021 20:38 UTC |
STACK DAVID MDirector · CEO and Chairman
|
GrantCommon Stock | 17,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040091 · doc4.xml · nonDerivative · entry 1 STACK DAVID M · CIK 0001204788 · Director · CEO and Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,956 F1 · shares: Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2022, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
| June 09, 2021 Filed Jun 12, 2021 00:47 UTC |
PACE GARY WDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,626 | $0.00 Strike: $60.96 | $0.00 |
DisclosureSEC source: 0001209191-21-040097 · doc4.xml · derivative · entry 3 PACE GARY W · CIK 0001184778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,626 Underlying: Common Stock · 7,626 shares Expires 2031-06-09 Read SEC document |
| June 09, 2021 Filed Jun 12, 2021 00:47 UTC |
PACE GARY WDirector
|
GrantCommon Stock | 1,066 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040097 · doc4.xml · nonDerivative · entry 2 PACE GARY W · CIK 0001184778 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,530 F1 · shares: Represents restricted stock units that vest on June 3, 2022, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.